XML 13 R2.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Income Statement [Abstract]        
Net sales $ 367,224 $ 325,130 $ 1,031,825 $ 742,209
Cost of goods sold 227,032 220,073 660,396 486,224
Gross profit 140,192 105,057 371,429 255,985
Selling, general and administrative expenses 97,037 80,812 282,405 182,293
Indefinite-lived intangible asset impairment 0 0 38,000 0
Restructuring and related charges 1,383 24,045 3,585 24,045
Combination, integration and other acquisition-related expenses 6,913 14,702 22,786 23,789
Operating income (loss) 34,859 (14,502) 24,653 25,858
Other (expense) income, net (239) 203 (22,407) (389)
Interest expense, net (6,837) (6,102) (22,109) (7,611)
Income (loss) before taxes and equity in net income of associated companies 27,783 (20,401) (19,863) 17,858
Taxes on income (loss) before equity in net income of associated companies 2,245 (5,633) (7,603) 4,096
Income (loss) before equity in net income of associated companies 25,538 (14,768) (12,260) 13,762
Equity in net income of associated companies 1,804 1,787 3,536 2,806
Net income (loss) 27,342 (12,981) (8,724) 16,568
Less: Net income attributable to noncontrolling interest 38 72 88 186
Net income (loss) attributable to Quaker Chemical Corporation $ 27,304 $ (13,053) $ (8,812) $ 16,382
Per share data:        
Basic earnings (loss) per common share $ 1.53 $ (0.80) $ (0.50) $ 1.15
Diluted earnings (loss) per common share 1.53 (0.80) (0.50) 1.14
Dividends Declared $ 0.395 $ 0.385 $ 1.165 $ 1.140